Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tilman Brummer

Showing results (1-10 of 118) with videos related to

Pageof 12
Sort By:
Oncogene|April 10, 2020
RAF kinase dimerization: implications for drug discovery and clinical outcomesTilman Brummer, Campbell McInnes
Cell Cycle (Georgetown, Tex.)|April 22, 2016
B-Raf activation loop phosphorylation revisitedMartin Köhler, Tilman Brummer
Critical Reviews in Oncogenesis|April 5, 2012
Aberrant B-Raf signaling in human cancer -- 10 years from bench to bedsideMichael Röring, Tilman Brummer
Cells|August 9, 2024
Enzyme Is the Name-Adapter Is the GameMichael Huber, Tilman Brummer
Molecular & Cellular Oncology|June 17, 2016
BRAF inhibitors in colorectal cancer: Toward a differentiation therapy?Ricarda Herr, Tilman Brummer
Nature Reviews. Immunology|April 2, 2004
Feedback regulation of lymphocyte signallingMichael Reth, Tilman Brummer
Blood|July 19, 2023
The role of the MDM2/p53 axis in antitumor immune responsesTilman Brummer, Robert Zeiser
Methods in Molecular Biology (Clifton, N.J.)|September 2, 2016
Quantitative Proteomics Analysis of Leukemia CellsSebastian Halbach, Jörn Dengjel, Tilman Brummer
Circulation Journal : Official Journal of the Japanese Circulation Society|July 13, 2012
The versatile role of Gab1 in the circulatory systemFranziska U Wöhrle, Sebastian Halbach, Tilman Brummer
The FEBS Journal|October 2, 2010
Docking proteinsTilman Brummer, Carsten Schmitz-Peiffer, Roger J Daly
Pageof 12

Showing results (1-10 of 118) with videos related to

Sort By:
Pageof 12
Oncogene|April 10, 2020
RAF kinase dimerization: implications for drug discovery and clinical outcomesTilman Brummer, Campbell McInnes
Cell Cycle (Georgetown, Tex.)|April 22, 2016
B-Raf activation loop phosphorylation revisitedMartin Köhler, Tilman Brummer
Critical Reviews in Oncogenesis|April 5, 2012
Aberrant B-Raf signaling in human cancer -- 10 years from bench to bedsideMichael Röring, Tilman Brummer
Cells|August 9, 2024
Enzyme Is the Name-Adapter Is the GameMichael Huber, Tilman Brummer
Molecular & Cellular Oncology|June 17, 2016
BRAF inhibitors in colorectal cancer: Toward a differentiation therapy?Ricarda Herr, Tilman Brummer
Nature Reviews. Immunology|April 2, 2004
Feedback regulation of lymphocyte signallingMichael Reth, Tilman Brummer
Blood|July 19, 2023
The role of the MDM2/p53 axis in antitumor immune responsesTilman Brummer, Robert Zeiser
Methods in Molecular Biology (Clifton, N.J.)|September 2, 2016
Quantitative Proteomics Analysis of Leukemia CellsSebastian Halbach, Jörn Dengjel, Tilman Brummer
Circulation Journal : Official Journal of the Japanese Circulation Society|July 13, 2012
The versatile role of Gab1 in the circulatory systemFranziska U Wöhrle, Sebastian Halbach, Tilman Brummer
The FEBS Journal|October 2, 2010
Docking proteinsTilman Brummer, Carsten Schmitz-Peiffer, Roger J Daly
Pageof 12